The common link between functional somatic syndromes may be central sensitisation

Journal of Psychosomatic Research

Volumn 78, Issue 3, 2015, Pages 228-236

  Bourke, Julius H ^a   Langford, Richard M ^b   White, Peter D ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Central sensitisation; Chronic pain; Functional somatic syndromes; Neurophysiology; Pathophysiology

Indexed keywords

ANXIETY DISORDER; ARTICLE; CENTRAL NERVOUS SYSTEM SENSITIZATION; CHRONIC PAIN; ENDOPHENOTYPE; FATIGUE; FUNCTIONAL SOMATIC SYNDROME; HUMAN; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NOCICEPTION; PERSONAL EXPERIENCE; POSTTRAUMATIC STRESS DISORDER; PROSPECTIVE STUDY; RISK FACTOR; SENSORY STIMULATION; SLEEP DISORDER; SPINAL CORD DORSAL HORN; TEMPORAL SUMMATION; PAIN; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PSYCHOLOGY; PSYCHOSOMATIC DISORDER; SYNDROME;

CENTRAL NERVOUS SYSTEM SENSITIZATION; HUMANS; PAIN; PAIN MEASUREMENT; PSYCHOPHYSIOLOGIC DISORDERS; SYNDROME;

EID: 84922851330     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2015.01.003     Document Type: Article

References (186)

1. Prins JB, van der Meer JW, Bleijenberg G Chronic fatigue syndrome. Lancet 2006, 367:346-355.
2. Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, et al. The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes 2011, 9:71.
3. Creed F, Guthrie E, Fink P, Henningsen P, Rief W, Sharpe M, et al. Is there a better term than "medically unexplained symptoms"?. J Psychosom Res 2010, 68:5-8.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Publishing, Arlington, VA.
5. White PD, Rickards H, Zeman AZ Time to end the distinction between mental and neurological illnesses. BMJ 2012, 344:e3454.
6. Wessely S, White PD There is only one functional somatic syndrome. Br J Psychiatry 2004, 185:95-96.
7. White PD Functional somatic syndromes may be either "polysyndromic" or "monosyndromic". J Psychosom Res 2013, 74:2-3.
8. Aaron LA, Buchwald D A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 2001, 134:868-881.
9. Whitehead WE, Palsson O, Jones KR Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 2002, 122:1140-1156.
10. Moss-Morris R, Spence M To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome?. Psychosom Med 2006, 68:463-469.
11. Hamilton WT, Gallagher AM, Thomas JM, White PD Risk markers for both chronic fatigue and irritable bowel syndromes: a prospective case-control study in primary care. Psychol Med 2009, 39:1913-1921.
12. Goldenberg DL Pain/depression dyad: a key to a better understanding and treatment of functional somatic syndromes. Am J Med 2010, 123:675-682.
13. Phillips K, Clauw DJ Central pain mechanisms in chronic pain states - maybe it is all in their head. Best Pract Res Clin Rheumatol 2011, 25:141-154.
14. Nijs J, Meeus M, Van Oosterwijck J, Ickmans K, Moorkens G, Hans G, et al. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur J Clin Invest 2012, 42:203-212.
15. Kidd BL, Urban LA Mechanisms of inflammatory pain. Br J Anaesth 2001, 87:3-11.
16. Treede R-D Chapter 1. Pain and hyperalgesia: definitions and theories. Handb Clin Neurol 2006, 81:3-10.
17. Treede RD, Kenshalo DR, Gracely RH, Jones AK The cortical representation of pain. Pain 1999, 79:105-111.
18. Light AR, Sedivec MJ, Casale EJ, Jones SL Physiological and morphological characteristics of spinal neurons projecting to the parabrachial region of the cat. Somatosens Mot Res 1993, 10:309-325.
19. Woolf CJ, Fitzgerald M The properties of neurones recorded in the superficial dorsal horn of the rat spinal cord. J Comp Neurol 1983, 221:313-328.
20. Melzack R Pain and the neuromatrix in the brain. J Dent Educ 2001, 65:1378-1382.
21. Melzack R Labat lecture. Phantom limbs. Reg Anesth 1989, 14:208-211.
22. Wall PD, Bery J, Saade N Effects of lesions to rat spinal cord lamina I cell projection pathways on reactions to acute and chronic noxious stimuli. Pain 1988, 35:327-339.
23. Baranauskas G, Nistri A Sensitization of pain pathways in the spinal cord: cellular mechanisms. Prog Neurobiol 1998, 54:349-365.
24. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001, 410:471-475.
25. Cao H, Zhang YQ Spinal glial activation contributes to pathological pain states. Neurosci Biobehav Rev 2008, 32:972-983.
26. Minami T, Okuda-Ashitaka E, Hori Y, Sakuma S, Sugimoto T, Sakimura K, et al. Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2. Eur J Neurosci 1999, 11:1849-1856.
27. Millan MJ Descending control of pain. Prog Neurobiol 2002, 66:355-474.
28. Graven-Nielsen T, Arendt-Nielsen L Peripheral and central sensitization in musculoskeletal pain disorders: an experimental approach. Curr Rheumatol Rep 2002, 4:313-321.
29. Gracely RH, Grant MA, Giesecke T Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 2003, 17:593-609.
30. Arendt-Nielsen L, Fernandez-de-Las-Penas C, Graven-Nielsen T Basic aspects of musculoskeletal pain: from acute to chronic pain. J Man Manip Ther 2011, 19:186-193.
31. Chun A, Desautels S, Slivka A, Mitrani C, Starz T, DiLorenzo C, et al. Visceral algesia in irritable bowel syndrome, fibromyalgia, and sphincter of oddi dysfunction, type III. Dig Dis Sci 1999, 44:631-636.
32. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995, 109:40-52.
33. Julien N, Goffaux P, Arsenault P, Marchand S Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005, 114:295-302.
34. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001, 91:165-175.
35. Meeus M, Nijs J, Van de Wauwer N, Toeback L, Truijen S Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: an experimental study. Pain 2008, 139:439-448.
36. Vecchiet L, Montanari G, Pizzigallo E, Iezzi S, de Bigontina P, Dragani L, et al. Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome. Neurosci Lett 1996, 208:117-120.
37. Arendt-Nielsen L, Yarnitsky D Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. J Pain 2009, 10:556-572.
38. Wilder-Smith OH, Tassonyi E, Crul BJ, Arendt-Nielsen L Quantitative sensory testing and human surgery: effects of analgesic management on postoperative neuroplasticity. Anesthesiology 2003, 98:1214-1222.
39. Woolf CJ, Salter MW Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1769.
40. Woolf CJ Windup and central sensitization are not equivalent. Pain 1996, 66:105-108.
41. Ingvar M Pain and functional imaging. Philos Trans R Soc Lond B Biol Sci 1999, 354:1347-1358.
42. Borsook D, Moulton EA, Schmidt KF, Becerra LR Neuroimaging revolutionizes therapeutic approaches to chronic pain. Mol Pain 2007, 3:25.
43. Legrain V, Iannetti GD, Plaghki L, Mouraux A The pain matrix reloaded: a salience detection system for the body. Prog Neurobiol 2011, 93:111-124.
44. Newton J, Brown MA, Milicic A, Ackerman H, Darke C, Wilson JN, et al. The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor haplotype. Arthritis Rheum 2003, 48:90-96.
45. Lange G, Steffener J, Cook DB, Bly BM, Christodoulou C, Liu WC, et al. Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. Neuroimage 2005, 26:513-524.
46. Gerster JC, Hadj-Djilani A Hearing and vestibular abnormalities in primary fibrositis syndrome. J Rheumatol 1984, 11:678-680.
47. Peyron R, Frot M, Schneider F, Garcia-Larrea L, Mertens P, Barral FG, et al. Role of operculoinsular cortices in human pain processing: converging evidence from PET, fMRI, dipole modeling, and intracerebral recordings of evoked potentials. Neuroimage 2002, 17:1336-1346.
48. Craig AD Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol 2003, 13:500-505.
49. Critchley HD, Mathias CJ, Dolan RJ Fear conditioning in humans: the influence of awareness and autonomic arousal on functional neuroanatomy. Neuron 2002, 33:653-663.
50. Gray MA, Harrison NA, Wiens S, Critchley HD Modulation of emotional appraisal by false physiological feedback during fMRI. PLoS One 2007, 2:e546.
51. Balleine BW, Dickinson A The effect of lesions of the insular cortex on instrumental conditioning: evidence for a role in incentive memory. J Neurosci 2000, 20:8954-8964.
52. Singer T, Critchley HD, Preuschoff K A common role of insula in feelings, empathy and uncertainty. Trends Cogn Sci 2009, 13:334-340.
53. Itti L, Koch C Computational modelling of visual attention. Nat Rev Neurosci 2001, 2:194-203.
54. Iannetti GD, Zambreanu L, Tracey I Similar nociceptive afferents mediate psychophysical and electrophysiological responses to heat stimulation of glabrous and hairy skin in humans. J Physiol 2006, 577:235-248.
55. Iannetti GD, Hughes NP, Lee MC, Mouraux A Determinants of laser-evoked EEG responses: pain perception or stimulus saliency?. J Neurophysiol 2008, 100:815-828.
56. Naatanen R, Paavilainen P, Rinne T, Alho K The mismatch negativity (MMN) in basic research of central auditory processing: a review. Clin Neurophysiol 2007, 118:2544-2590.
57. Zink CF, Pagnoni G, Martin ME, Dhamala M, Berns GS Human striatal response to salient nonrewarding stimuli. J Neurosci 2003, 23:8092-8097.
58. Corbetta M, Shulman GL Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci 2002, 3:201-215.
59. Legrain V, Damme SV, Eccleston C, Davis KD, Seminowicz DA, Crombez G A neurocognitive model of attention to pain: behavioral and neuroimaging evidence. Pain 2009, 144:230-232.
60. Iannetti GD, Mouraux A From the neuromatrix to the pain matrix (and back). Exp Brain Res 2010, 205:1-12.
61. Belmonte C, Viana F Molecular and cellular limits to somatosensory specificity. Mol Pain 2008, 4:14.
62. Pincus T, Morley S Cognitive-processing bias in chronic pain: a review and integration. Psychol Bull 2001, 127:599-617.
63. Maixner W, Fillingim R, Sigurdsson A, Kincaid S, Silva S Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain 1998, 76:71-81.
64. Edwards RR, Ness TJ, Weigent DA, Fillingim RB Individual differences in diffuse noxious inhibitory controls (DNIC): association with clinical variables. Pain 2003, 106:427-437.
65. Langemark M, Bach FW, Jensen TS, Olesen J Decreased nociceptive flexion reflex threshold in chronic tension-type headache. Arch Neurol 1993, 50:1061-1064.
66. Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 2004, 50:613-623.
67. Ness TJ Pelvic pain in women and men: recent findings. Curr Opin Anaesthesiol 2005, 18:555-562.
68. Rodriguez MA, Afari N, Buchwald DS Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol 2009, 182:2123-2131.
69. Tillisch K, Mayer EA, Labus JS Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 2011, 140:91-100.
70. Gracely RH, Petzke F, Wolf JM, Clauw DJ Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002, 46:1333-1343.
71. Cook DB, O'Connor PJ, Lange G, Steffener J Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls. Neuroimage 2007, 36:108-122.
72. Abrahamsen R, Dietz M, Lodahl S, Roepstorff A, Zachariae R, Ostergaard L, et al. Effect of hypnotic pain modulation on brain activity in patients with temporomandibular disorder pain. Pain 2010, 151:825-833.
73. Farmer MA, Chanda ML, Parks EL, Baliki MN, Apkarian AV, Schaeffer AJ Brain functional and anatomical changes in chronic prostatitis/chronic pelvic pain syndrome. J Urol 2011, 186:117-124.
74. Bryson HM, Wilde MI Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states. Drugs Aging 1996, 8:459-476.
75. Brennan BP, Fogarty KV, Roberts JL, Reynolds KA, Pope HG, Hudson JI Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study. Hum Psychopharmacol 2009, 24:423-428.
76. Arnold LM, Clauw D, Wang F, Ahl J, Gaynor PJ, Wohlreich MM Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2010, 37:2578-2586.
77. Grover M, Dorn SD, Weinland SR, Dalton CB, Gaynes BN, Drossman DA Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders. Dig Dis Sci 2009, 54:1284-1291.
78. Pardini M, Guida S, Primavera A, Krueger F, Cocito L, Gialloreti LE. Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study. Eur Neuropsychopharmacol.21(3):282-6.
79. Arnold LM, Crofford LJ, Martin SA, Young JP, Sharma U The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. Pain Med 2007, 8:633-638.
80. Arnold BS, Alpers GW, Suss H, Friedel E, Kosmutzky G, Geier A, et al. Affective pain modulation in fibromyalgia, somatoform pain disorder, back pain, and healthy controls. Eur J Pain 2008, 12:329-338.
81. Yunus MB Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007, 36:339-356.
82. Kato K, Sullivan PF, Evengard B, Pedersen NL Premorbid predictors of chronic fatigue. Arch Gen Psychiatry 2006, 63:1267-1272.
83. Williams DA, Clauw DJ Understanding fibromyalgia: lessons from the broader pain research community. J Pain 2009, 10:777-791.
84. Paras ML, Murad MH, Chen LP, Goranson EN, Sattler AL, Colbenson KM, et al. Sexual abuse and lifetime diagnosis of somatic disorders: a systematic review and meta-analysis. JAMA 2009, 302:550-561.
85. Afari N, Ahumada SM, Wright LJ, Mostoufi S, Golnari G, Reis V, et al. Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis. Psychosom Med 2014, 76:2-11.
86. McBeth J, Silman AJ, Gupta A, Chiu YH, Ray D, Morriss R, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum 2007, 56:360-371.
87. Heim C, Nater UM, Maloney E, Boneva R, Jones JF, Reeves WC Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch Gen Psychiatry 2009, 66:72-80.
88. Fries E, Hesse J, Hellhammer J, Hellhammer DH A new view on hypocortisolism. Psychoneuroendocrinology 2005, 30:1010-1016.
89. Smith AK, White PD, Aslakson E, Vollmer-Conna U, Rajeevan MS Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 2006, 7:387-394.
90. Dannlowski U, Stuhrmann A, Beutelmann V, Zwanzger P, Lenzen T, Grotegerd D, et al. Limbic scars: long-term consequences of childhood maltreatment revealed by functional and structural magnetic resonance imaging. Biol Psychiatry 2012, 71:286-293.
91. McEwen BS Understanding the potency of stressful early life experiences on brain and body function. Metabolism 2008, 57:S11-S15.
92. Uher R, Weaver ICG Epigenetic traces of childhood maltreatment in peripheral blood: a new strategy to explore gene-environment interactions. Br J Psychiatry 2014, 204:3-5.
93. Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008, 33:693-710.
94. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum 2004, 50:944-952.
95. Kato K, Sullivan PF, Evengard B, Pedersen NL Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 2006, 166:1649-1654.
96. Kato K, Sullivan PF, Evengard B, Pedersen NL A population-based twin study of functional somatic syndromes. Psychol Med 2009, 39:497-505.
97. Diatchenko L, Nackley AG, Slade GD, Fillingim RB, Maixner W Idiopathic pain disorders - pathways of vulnerability. Pain 2006, 123:226-230.
98. Mogil JS The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci U S A 1999, 96:7744-7751.
99. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299:1240-1243.
100. Schmahl C, Ludascher P, Greffrath W, Kraus A, Valerius G, Schulze TG, et al. COMT val158met polymorphism and neural pain processing. PLoS One 2012, 7:e23658.
101. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005, 14:135-143.
102. Shughrue PJ, Lane MV, Merchenthaler I Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J Comp Neurol 1997, 388:507-525.
103. Riley JL, Robinson ME, Wise EA, Price DD A meta-analytic review of pain perception across the menstrual cycle. Pain 1999, 81:225-235.
104. Houghton LA, Lea R, Jackson N, Whorwell PJ The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut 2002, 50:471-474.
105. Norbury TA, MacGregor AJ, Urwin J, Spector TD, McMahon SB Heritability of responses to painful stimuli in women: a classical twin study. Brain 2007, 130:3041-3049.
106. Marquez de Prado B, Hammond DL, Russo AF Genetic enhancement of calcitonin gene-related peptide-induced central sensitization to mechanical stimuli in mice. J Pain 2009, 10:992-1000.
107. Karling P, Danielsson A, Wikgren M, Soderstrom I, Del-Favero J, Adolfsson R, et al. The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome. PLoS One 2011, 6:e18035.
108. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 2003, 23:104-107.
109. Goertzel BN, Pennachin C, de Souza Coelho L, Gurbaxani B, Maloney EM, Jones JF Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics 2006, 7:475-483.
110. Vollmer-Conna U, Aslakson E, White PD An empirical delineation of the heterogeneity of chronic unexplained fatigue in women. Pharmacogenomics 2006, 7:355-364.
111. Henningsen P, Zimmermann T, Sattel H Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 2003, 65:528-533.
112. Goodwin L, White PD, Hotopf M, Stansfeld SA, Clark C Psychopathology and physical activity as predictors of chronic fatigue syndrome in the 1958 British birth cohort: a replication study of the 1946 and 1970 birth cohorts. Ann Epidemiol 2011, 21:343-350.
113. Clark C, Goodwin L, Stansfeld SA, Hotopf M, White PD Premorbid risk markers for chronic fatigue syndrome in the 1958 British birth cohort. Br J Psychiatry 2011, 199:323-329.
114. Adler G, Gattaz WF Pain perception threshold in major depression. Biol Psychiatry 1993, 34:687-689.
115. Lautenbacher S, Krieg JC Pain perception in psychiatric disorders: a review of the literature. J Psychiatr Res 1994, 28:109-122.
116. Bar KJ, Brehm S, Boettger MK, Boettger S, Wagner G, Sauer H Pain perception in major depression depends on pain modality. Pain 2005, 117:97-103.
117. Merskey H The effect of chronic pain upon the response to noxious stimuli by psychiatric patients. J Psychosom Res 1965, 8:405-419.
118. Klauenberg S, Maier C, Assion HJ, Hoffmann A, Krumova EK, Magerl W, et al. Depression and changed pain perception: hints for a central disinhibition mechanism. Pain 2008, 140:332-343.
119. Defrin R, Ginzburg K, Solomon Z, Polad E, Bloch M, Govezensky M, et al. Quantitative testing of pain perception in subjects with PTSD - implications for the mechanism of the coexistence between PTSD and chronic pain. Pain 2008, 138:450-459.
120. Amital D, Fostick L, Polliack ML, Segev S, Zohar J, Rubinow A, et al. Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities?. J Psychosom Res 2006, 61:663-669.
121. Asmundson GJ, Coons MJ, Taylor S, Katz J PTSD and the experience of pain: research and clinical implications of shared vulnerability and mutual maintenance models. Can J Psychiatry 2002, 47:930-937.
122. Armour C, Karstoft KI, Richardson JD The co-occurrence of PTSD and dissociation: differentiating severe PTSD from dissociative-PTSD. Soc Psychiatry Psychiatr Epidemiol 2014, 49:1297-1306.
123. Ji RR, Woolf CJ Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 2001, 8:1-10.
124. Norman SB, Stein MB, Dimsdale JE, Hoyt DB Pain in the aftermath of trauma is a risk factor for post-traumatic stress disorder. Psychol Med 2008, 38:533-542.
125. Holbrook TL, Galarneau MR, Dye JL, Quinn K, Dougherty AL Morphine use after combat injury in Iraq and post-traumatic stress disorder. N Engl J Med 2010, 362:110-117.
126. White KP, Speechley M, Harth M, Ostbye T The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 1999, 26:1577-1585.
127. Bellini M, Gemignani A, Gambaccini D, Toti S, Menicucci D, Stasi C, et al. Evaluation of latent links between irritable bowel syndrome and sleep quality. World J Gastroenterol 2011, 17:5089-5096.
128. Unger ER, Nisenbaum R, Moldofsky H, Cesta A, Sammut C, Reyes M, et al. Sleep assessment in a population-based study of chronic fatigue syndrome. BMC Neurol 2004, 4:6.
129. Sharpley A, Clements A, Hawton K, Sharpe M Do patients with "pure" chronic fatigue syndrome (neurasthenia) have abnormal sleep?. Psychosom Med 1997, 59:592-596.
130. Ohayon MM, Roth T What are the contributing factors for insomnia in the general population?. J Psychosom Res 2001, 51:745-755.
131. Chen CL, Liu TT, Yi CH, Orr WC Evidence for altered anorectal function in irritable bowel syndrome patients with sleep disturbance. Digestion 2011, 84:247-251.
132. Psychiatric Association American Diagnostic and statistical manual of mental disorders, text revision (DSM-IV-TR) 2000, American Psychiatric Association. 4th ed.
133. Ohayon MM Prevalence and correlates of nonrestorative sleep complaints. Arch Intern Med 2005, 165:35-41.
134. Pivik RT, Harman K A reconceptualization of EEG alpha activity as an index of arousal during sleep: all alpha activity is not equal. J Sleep Res 1995, 4:131-137.
135. Whelton CL, Salit I, Moldofsky H Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. J Rheumatol 1992, 19:939-943.
136. Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001, 44:222-230.
137. Roehrs T, Hyde M, Blaisdell B, Greenwald M, Roth T Sleep loss and REM sleep loss are hyperalgesic. Sleep 2006, 29:145-151.
138. Moldofsky H The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes. Joint Bone Spine 2008, 75:397-402.
139. Ablin JN, Clauw DJ, Lyden AK, Ambrose K, Williams DA, Gracely RH, et al. Effects of sleep restriction and exercise deprivation on somatic symptoms and mood in healthy adults. Clin Exp Rheumatol 2013, 31:S53-S59.
140. Bigatti SM, Hernandez AM, Cronan TA, Rand KL Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum 2008, 59:961-967.
141. Onen SH, Alloui A, Gross A, Eschallier A, Dubray C The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res 2001, 10:35-42.
142. Smith MT, Edwards RR, McCann UD, Haythornthwaite JA The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007, 30:494-505.
143. Lovati C, D'Amico D, Bertora P, Raimondi E, Rosa S, Zardoni M, et al. Correlation between presence of allodynia and sleep quality in migraineurs. Neurol Sci 2010, 31:S155-S158.
144. Lavigne G, Brousseau M, Kato T, Mayer P, Manzini C, Guitard F, et al. Experimental pain perception remains equally active over all sleep stages. Pain 2004, 110:646-655.
145. Vollmer-Conna U, Gunawardane U, Patel V, Cvejic E, Lloyd AR 39. Vagus nerve activity, a good night's sleep, and recovery from acute infection. Brain Behav Immun 2013, 32:e11-e12.
146. Tillisch K, Labus J, Nam B, Bueller J, Smith S, Suyenobu B, et al. Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study. Aliment Pharmacol Ther 2012, 35:360-367.
147. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994, 37:1593-1601.
148. Andersen ML, Nascimento DC, Machado RB, Roizenblatt S, Moldofsky H, Tufik S Sleep disturbance induced by substance P in mice. Behav Brain Res 2006, 167:212-218.
149. Bennett RM Adult growth hormone deficiency in patients with fibromyalgia. Curr Rheumatol Rep 2002, 4:306-312.
150. Bennett RM, Clark SC, Walczyk J A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 1998, 104:227-231.
151. Leese G, Chattington P, Fraser W, Vora J, Edwards R, Williams G Short-term night-shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome. J Clin Endocrinol Metab 1996, 81:1867-1870.
152. Heim C, Ehlert U, Hellhammer DH The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
153. al'Absi M, Petersen KL, Wittmers LE Adrenocortical and hemodynamic predictors of pain perception in men and women. Pain 2002, 96:197-204.
154. Lariviere WR, Melzack R The role of corticotropin-releasing factor in pain and analgesia. Pain 2000, 84:1-12.
155. Tak LM, Cleare AJ, Ormel J, Manoharan A, Kok IC, Wessely S, et al. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol Psychol 2011, 87:183-194.
156. Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA, et al. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 2004, 18:314-325.
157. Vanuytsel T, van Wanrooy S, Vanheel H, Vanormelingen C, Verschueren S, Houben E, et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut 2013, 63:1293-1299.
158. Martinez-Lavin M, Hermosillo AG Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin Arthritis Rheum 2000, 29:197-199.
159. Heitkemper M, Jarrett M, Cain KC, Burr R, Levy RL, Feld A, et al. Autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci 2001, 46:1276-1284.
160. Burton AR, Rahman K, Kadota Y, Lloyd A, Vollmer-Conna U Reduced heart rate variability predicts poor sleep quality in a case-control study of chronic fatigue syndrome. Experimental brain research Experimentelle Hirnforschung Experimentation cerebrale 2010, 204:71-78.
161. Martinez-Lavin M Is fibromyalgia a generalized reflex sympathetic dystrophy?. Clin Exp Rheumatol 2001, 19:1-3.
162. Oppenheimer SM, Gelb A, Girvin JP, Hachinski VC Cardiovascular effects of human insular cortex stimulation. Neurology 1992, 42:1727-1732.
163. Newton JL, Okonkwo O, Sutcliffe K, Seth A, Shin J, Jones DEJ Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM 2007, 100:519-526.
164. Van Den Eede F, Moorkens G, Van Houdenhove B, Cosyns P, Claes SJ Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. Neuropsychobiology 2007, 55:112-120.
165. Meeus M, Nijs J Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 2007, 26:465-473.
166. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH An association between migraine and cutaneous allodynia. Ann Neurol 2000, 47:614-624.
167. Graven-Nielsen T, Wodehouse T, Langford RM, Arendt-Nielsen L, Kidd BL Normalization of widespread hyperesthesia and facilitated spatial summation of deep-tissue pain in knee osteoarthritis patients after knee replacement. Arthritis Rheum 2012, 64:2907-2916.
168. Gottesman II, Gould TD The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160:636-645.
169. Gershon ES, Goldin LR Clinical methods in psychiatric genetics. I. Robustness of genetic marker investigative strategies. Acta Psychiatr Scand 1986, 74:113-118.
170. Leboyer M, Bellivier F, Nosten-Bertrand M, Jouvent R, Pauls D, Mallet J Psychiatric genetics: search for phenotypes. Trends Neurosci 1998, 21:102-105.
171. Mayer EA The search for biomarkers and endophenotypes in functional gastrointestinal disorders. Gastroenterology 2011, 140:1377-1379.
172. Crombez G, Beirens K, Van Damme S, Eccleston C, Fontaine J The unbearable lightness of somatisation: a systematic review of the concept of somatisation in empirical studies of pain. Pain 2009, 145:31-35.
173. Frances A The new somatic symptom disorder in DSM-5 risks mislabeling many people as mentally ill. BMJ 2013, 346:f1580.
174. Morriss RK, Ahmed M, Wearden AJ, Mullis R, Strickland P, Appleby L, et al. The role of depression in pain, psychophysiological syndromes and medically unexplained symptoms associated with chronic fatigue syndrome. J Affect Disord 1999, 55:143-148.
175. Fischler B, Dendale P, Michiels V, Cluydts R, Kaufman L, De Meirleir K Physical fatigability and exercise capacity in chronic fatigue syndrome: association with disability, somatization and psychopathology. J Psychosom Res 1997, 42:369-378.
176. Sharpe M Cognitive behavior therapy for chronic fatigue syndrome: efficacy and implications. Am J Med 1998, 105:104S-109S.
177. Waddell G, Newton M, Henderson I, Somerville D, Main CJ A Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain 1993, 52:157-168.
178. Vlaeyen JW, Linton SJ Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 2000, 85:317-332.
179. Silver A, Haeney M, Vijayadurai P, Wilks D, Pattrick M, Main CJ The role of fear of physical movement and activity in chronic fatigue syndrome. J Psychosom Res 2002, 52:485-493.
180. Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, et al. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 2009, 21:149-159.
181. Zhou Q, Fillingim RB, Riley JL, Malarkey WB, Verne GN Central and peripheral hypersensitivity in the irritable bowel syndrome. Pain 2010, 148:454-461.
182. Paiva ES, Deodhar A, Jones KD, Bennett R Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. Arthritis Rheum 2002, 46:1344-1350.
183. Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 1998, 25:1374-1381.
184. Gur A, Cevik R, Nas K, Colpan L, Sarac S Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Res Ther 2004, 6:R232-R238.
185. Roberts AD, Wessely S, Chalder T, Papadopoulos A, Cleare AJ Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry 2004, 184:136-141.
186. Heim C, Ehlert U, Hanker JP, Hellhammer DH Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom Med 1998, 60:309-318.